Macrophage-mediated effector mechanisms against the protozoan parasite Entamoeba histolytica were studied. Unstimulated macrophages were inefficient at killing E. histolytica trophozoites in vitro and were killed by the trophozoites. Conversely, immature cells of the mononuclear phagocyte lineage (promonocytes) were shown to display a strong spontaneous amebicidal activity. The acquisition of macrophage amebicidal activity following cytokine treatment was investigated. Gamma interferon, tumor necrosis factor alpha, and macrophage colony-stimulating factor 1, or combinations thereof, were shown to endow murine bone marrowderived macrophages with significant amebicidal activity. Low doses of gamma interferon and tumor necrosis factor alpha and of gamma interferon and colony-stimulating factor 1 were shown to act synergistically in this phenomenon. This enhancement of amebicidal activity was shown to operate on bone marrow-derived macrophages, elicited peritoneal macrophages, and, to a much lesser extent, spleen macrophages. Although acquisition of amebicidal activity was associated with a strong respiratory burst, the addition of oxygen-free radical scavengers showed that the killing activity was approximately 45% H202 dependent. In addition, amebicidal activity by macrophages was shown to be contact dependent and was inhibited by 61% with the protease inhibitor tosyl lysyl chloromethyl ketone. Our results indicate that immunologic production of gamma interferon, tumor necrosis factor alpha, and colony-stimulating factor 1 could be important in the activation of macrophages for host defense against amebiasis and that promonocytes are strong effector cells against virulent amebae.
Invasive amebiasis is a major health and social problem in certain areas of Africa, Asia, and Latin America. It has been estimated that 480 million people carry Entamoeba histolytica in their intestinal tracts; of these, 34 to 50 million develop invasive disease and 40,000 to 100,000 die yearly (29) . Relatively little is known about the mechanisms involved in resistance to invasive amebiasis (24, 27) . Cell-mediated immunity appears to be important in experimental models of amebiasis (10, 25, 27) . Ghadirian et al. (11) showed that protection against amebic liver abscess followed immunization with amebic proteins. Peripheral blood mononuclear cells, spleen cells, and peritoneal macrophages from immune animals killed amebic trophozoites in vitro (4) . In vivo models that use silica treatment have indicated a role for the macrophage in host defense against hepatic amebiasis (10) .
Human monocyte-derived macrophages from normal individuals, activated in vitro with crude lymphokines (LKs), can kill amebic trophozoites (22) . Recently, with the use of partially purified and recombinant gamma interferon (IFN-y) and monoclonal antibody to IFN--y, it was shown that IFN--y has a major but not exclusive role in activating human macrophages to kill virulent E. histolytica trophozoites (21, 22) .
The availability of recombinant cytokines as well as antibodies directed against these molecules has allowed us to examine their efficacy in stimulating the acquisition of antiamebic activity by murine macrophages and also to investigate the mechanisms involved in this interaction. Our studies show that immature cells of the mononuclear phagocyte lineage can exert a strong spontaneous amebicidal effect and that bone marrow (BM)-derived macrophages can be activated with IFN-y, tumor necrosis factor alpha (TNF-ox), or * COresponding author.
colony-stimulating factor 1 (CSF-1) or all three for potent synergistic amebicidal effects in vitro.
MATERIALS AND METHODS
Mice. Inbred BALB/c mice (8 to 12 weeks of age) were obtained from Charles River Breeding Laboratories, St. Constant, Quebec Canada. They were housed in plastic cages in pathogen-free conditions and fed water and Purina chow ad libitum.
Parasites. The pathogenic strain of E. histolytica used was HM1-IMSS grown axenically in TYI-S-33 medium as described previously (4) . Trophozoites were harvested during log-phase growth after 48 to 72 h of subculture by chilling the cultures in ice water (5 min) and sedimentation (300 x g, 10 min).
Macrophage populations. Peritoneal exudate cells were isolated by peritoneal lavage of mice injected intraperitoneally 3 days previously with 1.5 ml of 10% proteose peptone (Difco Laboratories, Detroit, Mich.). Cells were washed twice in complete medium (RPMI 1640 supplemented with 10% fetal calf serum and antibiotics) and plated in 35-mm petri dishes (5 x 106 per dish) for 2 h at 37°C in 5% C02-95% air, followed by removal of nonadherent cells by suction.
Spleen macrophages were obtained as described previously (7). BM-derived macrophages were obtained after in vitro culture of BM cells from murine femurs in the presence of L-cell supernatant (8) .
Macrophage-mediated killing. Macrophage amebicidal activity was assessed by a method described in detail elsewhere (6) . Adherent macrophages were dislodged by EDTA treatment as described previously (7) . In some cases, macrophages were preactivated by 18 with control, * = P < 0.01, ** = P < 0.001, and *** = P < 0.0001. (20 ng/ml) IFN-y (100 U/ml) + LPS 52 ± 11** 48 ± 4 (50 ng/ml) IFN-y (300 U/ml) + LPS 40 ± 10** 43 ± 6 (50 ng/ml) " All experiments were performed with BM-derived macrophages in a standard killing assay (effector/target ratio of 100:1 and 6-h incubation).
bMacrophages were incubated for 18 h with cytokines before interaction with amoebae.
' Means ± standard deviations of one set of experiments repeated twice with similar results. *P < 0.05 compared with untreated cells; **P < 0.01 compared with untreated cells.
amebae was 93 ± 3%, whereas viability of macrophages was 63 ± 12%.
It has been shown before that acquisition of amebicidal activity occurred in monocyte-derived human macrophages following activation with LKs; this activation was due, in part, to IFN--y as shown by depletion studies with anti-IFN-y antibodies (21) . Therefore, it was decided to probe further the potential of various cytokines to activate macrophages to kill amebae. Preliminary experiments showed that LK-rich fluid could activate peritoneal macrophages to kill amebae in 100 -P a standard assay system (68 ± 13% of killing; effector/target ratio of 100:1 after a 6-h incubation time). This acquisition of killing activity was neutralized by the addition of anti-IFN--y antibodies (1,500 neutralizing units/ml; 21 ± 16% killing of amebae) and to a lesser extent by anti-TNF antibodies (3,000 neutralizing units/ml; 51 ± 4% killing) as compared with 71 ± 6% in control cultures in the LK-rich fluid during the activation of effector macrophages.
In another set of experiments, recombinant IFN--y was used to activate BM-derived macrophages in the presence or absence of LPS. Table 1 shows that treatment of macrophage monolayers with 100 to 1,000 U of IFN--y 18 h before assessment of amebicidal activity led to significant killing of E. histolytica trophozoites in the absence of LPS (22 to 42% killing). The addition of LPS (20 to 50 ng/ml)-IFN--y preparations led to a significant increase in the percentage of amebicidal activity, indicating that two signals are required to express high levels of cytotoxicity against E. histolytica, as described in macrophage killing of amebae, tumor cells, and L. enrietti (9, 16, 17) . LPS (20 to 50 ,ug/ml) alone did not activate macrophages to kill amebae. Regardless of the macrophage activation regimem used, a high proportion (35 to 51%) of macrophages were killed during the interaction with amebae, whereas macrophages not in contact with amebae (i.e., incubated alone) consistently maintained >95% viability. Contrary to the findings of Salata et al. (22) , we could not see a correlation between levels of macrophage survival and amebicidal activity. The reason(s) for this discrepancy remains unclear. Control studies also showed that IFN--y with or without LPS at the doses used was not cytotoxic by itself against E. histolytica trophozoites in the absence of macrophages.
Other cytokines were tested, notably TNF-cx, to determine their potential to activate macrophages to express amebicidal activity. TNF-o, used at 10 and 102 U, was ineffective at enhancing killing of E. histolytica trophozoites by BMderived macrophages ( PEC, peritoneal exudate cells. b Compared with untreated controls: *P < 0.05; **P < 0.01; ***P < 0.001.
nomenon was seen in BM-derived macrophages treated with low doses of IFN--y (102 U/ml) and TNF-oa (102 to 103 U/mi).
These doses of cytokines were by themselves inefficient at enhancing amebicidal activity; however, in combination, they endowed BM-derived macrophages with significant (73 to 87%) killing activity. Treatment of macrophages with CSF-1 (102 and 104 U/mi) rendered BM-derived macrophages marginally amebicidal (P < 0.05). However, incubation of BM-derived macrophages with CSF-1 and IFN--y (103 U/ml) rendered macrophages highly cytotoxic (82% killing) for E. histolytica trophozoites in a synergistic fashion. Lack of amebicidal activity by IFN-y and TNF-a in the absence of macrophages. The above experiments did not distinguish between the possible role of TNF-a as stimulus of macrophage effector functions or as cytolytic molecules by itself, although the latter possibility was considered unlikely. Furthermore, synergy between IFN--y and TNF-a for direct tumor cell cytoxicity has been described previously (26) . Therefore, experiments were designed to probe the ability of IFN-y and TNF-a to kill amebae in the absence of viable macrophages. In three separate experiments, amebae in TYI-S-33 complete medium were supplemented with IFN--y or TNF-ca or both (100 to 1,000 U/ml), and after 20 to 72 h, the number of viable cells was assessed. The cytokines did not kill amebae or prevent parasite multiplication at the incubation times. In addition, macrophages treated with IFN--y and TNF-a at doses that induce amebicidal activity, which were subsequently fixed with formaldehyde, did not kill amebic trophozoites (0 to 4% killing in three different experiments). These results suggest that killing is performed only by viable activated cells and does not result from absorption of TNF-a on the cell surface.
Treatment of different populations of macrophages with active LKs. Having demonstrated that cytokines are involved in the acquisition of amebicidal activity by BMderived macrophages, we decided to investigate the effect of these cytokines on activation of other populations of macrophages to kill virulent amebae. Table 2 shows that the most potent combination, IFN-y and TNF-ca, failed to endow spleen macrophages with full amebicidal activity (about 20% amebic killing), whereas peritoneal macrophages were fully activated to kill up to 88% of amebae (Table 2) .
Respiratory burst in macrophages activated with various cytokines. To seek a possible link between respiratory burst activity and amebicidal activity, the release of H202 by activated macrophages was assessed following phorbol myristate acetate (PMA) triggering. Table 2 shows that BM-derived macrophages demonstrated enhanced burst after activation with TNF-a and IFN-y or combinations thereof. Since these preparations also endowed macrophages with high levels of amebicidal activity, this seemed to suggest a correlation between secretion of H202 and killing. However, some IFN--y and cytokine combinations which were relatively inactive at endowing cells with amebicidal activity were very efficient at priming macrophages for enhanced H202 release, indicative of a certain dissociation between H202 release and amebic killing. This was notable the case for spleen macrophages pretreated with TNF-a and IFN--y, which, although endowed with high H202 release potential, killed amebae to a marginal (20%), although significant, extent. This is in contrast to BM-derived macrophages treated with IFN-y and TNF-a that had the same level of respiratory burst activity but in which up to 73% amebicidal activity was observed ( Table 2) .
Dissection of the mechanism(s) of amebicidal activity in LK-LPS-activated macrophages. (i) Importance of macrophage-ameba contact. It was next decided to investigate further the mechanisms involved in the acquisition of amebicidal activity by macrophages. In the killing of most extracellular targets, binding to targets is a necessary step in the cytolysis (13, 15) . To assess the requirement for cell contact in the described amebidical activity, LK-LPS-activated peritoneal macrophages were separated from amebic trophozoites by using a membrane filter (0.45 ,um) permeated with pores that allowed movement of fluid, but not cells. In four experiments, the level of amebicidal activity decreased from 68 ± 4% when cells and amebae were not separated to 12 + 3% when they were separated by the filter, suggesting a requirement for contact.
(ii) Effect of protease inhibitors and inhibitors of protein synthesis. The effect of adding protease inhibitors to prevent amebicidal activity by activated peritoneal macrophages was tested. Only TLCK at 2 x 10-4 M significantly (62%) inhibited amebicidal activity. In contrast, bovine pancreatic trypsin inhibitor, oa-1-antitrypsin, and aprotinin were wholly inactive at reversing amebicidal activity. None of the reagents at the doses used were toxic for macrophages or amebae (Table 3) .
In addition, the effect of inhibiting protein synthesis on the ability of activated macrophages to kill amebic targets was probed. Results shown in Table 3 Amebic viability following interaction with macrophages in the absence of inhibitors was 43%. *P < 0.004 when compared with amebic killing by control macrophages exposed to diluent only. mutase, histidine, and mannitol were ineffective at preventing parasite death, thus suggesting involvement of H,O,, but not other oxygen-free radicals, in macrophage-mediated killing of amebic trophozoites.
DISCUSSION
The results we present show that potent amebicidal activity can be spontaneously performed by mouse promonocytes and murine macrophages activated with a variety of cytokines, following treatment with recombinant TNF-ox, recombinant IFN-y, and CSF-1. Furthermore, we identified some of the parameters involved in this killing activity.
Innate resistance represents the first defense of every organism against microbial, viral, and parasitic insults, especially in cases in which a quick drastic reduction of the pathogenic burden is decisive. Natural cytotoxic effectors have been described in a variety of systems, notably mediated by cytolytic activities of immature cells obtained from BM cultures (2) . This cytolytic activity encompassed a broad range of targets, from YAC-1 lymphoma cells to Leislhmaiaiii promastigotes and amastigotes and Caididla albic-ans (2. 3).
The effector cells mediating spontaneous cytotoxicity are heterogeneous. Much attention has been given to natural killer cells, large granular lymphocytes, and mature macrophages. Baccarini et al. (2) have recently described strong spontaneous cytotoxicity exerted by nonadherent nonphagocytic cells in the earlier stages of macrophage differentiation. Using virulent E. Ihistolytica trophozoites, we demonstrated that the nonphagocytic macrophage precursors are highly amebicidal. Of interest is that this cell type can be found in the spleen and liver of normal mice and in infected mice in Our study used a purification procedure described by others which led to >95% pure macrophage precursors. Of importance in our study was the finding that macrophage precursors were highly resistant to killing by E. histolytica, which is a very potent effector cell in its own right (2) . Accordingly, macrophage precursors proved to possess an overall amebicidal activity much more elevated than unstimulated mouse or human macrophages. The BM-derived macrophage precursor activity was lost during in vitro maturation to mature macrophages, as described previously for the competence to kill YAC-1 lymphoma cells and C.
(albi(c(llS (2) .
Another aspect studied in this report is the ability of various cytokines to endow macrophages with amebicidal activity as well as the mechanism(s) involved in this phenomenon. A first finding was the efficiency of recombinant IFN-y in mediating acquisition of amebicidal activity in both systems. In the mouse macrophage-ameba interaction, the addition of trace amounts of endotoxin (LPS) rendered IFN-y-activated murine macrophages more cytolytic for E. histobytica trophozoites, as had been demonstrated previously (9) .
Cytokines other than IFN--y were also used to activate murine macrophages to kill E. histiolvtica trophozoites in vitro. TNF-o. was found to be capable of endowing macrophages with significant amebicidal activity. Synergy between IFN-y and TNF-(x was seen when both cytokines were used at doses too low to activate killing by themselves. This synergy between IFN-y and TNF-(x has already been observed in macrophage killing of schistosomula and P815 mastocytoma targets (8) . CSF-1 also was shown to be quite active at endowing BM-derived macrophages with amebicidal activity. This is in keeping with recent reports describing the ability of CSF-1 to activate macrophages to perform superior effector functions (14, 30) .
The importance of oxidative intermediates in macrophage- (13) . Soluble cytolysins produced by activated macrophages, e.g., neutral serine protease (1), have been described previously by several groups (1, 28) . Various groups have reported inhibition of macrophage killing ability in the presence of the protease inhibitors bovine pancreatic trypsin inhibitor and TLCK (1) or in the presence of TLCK only (12, 13) . Of the tryptic and chymotryptic protease inhibitors used in our assay system, TLCK prevented parasite killing by up to 61%. This, together with the 45% inhibition of amebic killing with catalase, which scavenges H202, appears to be the mechanism by which macrophages exert a direct amebidical effect, i.e., a combination of oxidative (H202) and nonoxidative (proteases) mechanisms.
Patients treated for amebic liver abscess develop a cellmediated immune response against E. histolytica. This includes a specific T-lymphocyte proliferative response to amebic antigen production of LKs that activate macrophages in vitro and antigen-specific cytotoxic T-cell activity (20, 23, 24) . This had led to the widely accepted belief that invasive amebiasis triggers an efficient immune response in humans and other animals. Macrophages are among the cells which express this acquired resistance. This study indicates that cells of the macrophage compartment can either exert spontaneous cytotoxicity (promonocytes) or acquire this potential after appropriate cytokine treatment (macrophages) and can have important implications in host defense mechanisms against amebiasis.
